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Obesity and the relationship
between pre-hypertension
and chronic kidney disease:
can we really isolate the effect
of pre-hypertension?
To the Editor: We read with interest the article by Yano et al.1
entitled ‘Association between prehypertension and chronic kidney
disease in the Japanese general population.’ We commend the
authors on taking advantage of a large, unique data set to highlight
this putative risk factor for chronic kidney disease (CKD); the
study has important public health implications because of the
pervasive and increasing presence of pre-hypertension with high-
normal blood pressure (BP) (systolic BP between 130–139mmHg
or diastolic BP between 85–90mmHg). However, the study
provides only weak evidence that pre-hypertension with high-
normal BP is an independent risk factor for CKD.
The authors found a statistically signiﬁcant association between
pre-hypertension with high-normal BP and CKD in men only.
The association was small in size (odds ratio: 1.11 (95% conﬁ-
dence interval: 1.05–1.17), Table 3). It is unclear whether this small
association is clinically signiﬁcant; trivial effects may achieve
statistical signiﬁcance when sample sizes are large,2 as in this study.
Furthermore, the small association could be explained by residual
confounding.3 The study collected data on height and weight, but
not on waist circumference. Thus, the authors adjusted for obesity
deﬁned as body mass index X25cm2, but this is an imperfect
measure of obesity and may not reﬂect central obesity, which better
predicts the adverse metabolic impact of visceral fat.4 Had the
authors adjusted for central obesity, the relationship between pre-
hypertension and CKD in men may have been completely null.
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The Authors Reply: We thank Anand et al.1 for the
interest in our ﬁndings. As suggested, the odds ratio of
chronic kidney disease (CKD) risk in our male subjects with
prehypertension and a high–normal blood pressure (BP)
range seemed to be slight, although it was statistically
signiﬁcant.2 In spite of the substantially larger number of
female subjects (n¼ 142,293) compared with male subjects
(n¼ 89,732), the risk of CKD conferred by prehyper-
tension with high–normal BP was not signiﬁcant in female
subjects.2 Therefore, we cannot agree with Anand’s concern
that ‘trivial effects may achieve statistical signiﬁcance when
sample sizes are large.’ Residual confounding due to unknown
or incompletely measured characteristics could not be
excluded in the present study, although we performed an
adjustment with several clinical parameters. This concern is
the common, and unfortunately, inevitable issue in all clinical
investigations. To conﬁrm our ﬁndings, prospective studies
are now ongoing to assess whether prehypertension is
associated with an increased incidence of CKD compared
with optimal BP.
Our reply to the second suggestion is as follows: in the
present study, we evaluated waist circumference in 213,679
subjects (92%). We analyzed the risk of CKD conferred by
prehypertension or hypertension with adjustment for waist
circumference instead of body mass index. As a result, our
conclusion remains unchanged, i.e., only in men prehyper-
tension in the high–normal BP range is associated with CKD
independently of signiﬁcant covariates, including waist
circumference (odds ratio (95% conﬁdence interval): 1.09
(1.03–1.15), P¼ 0.003).
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